Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2809-2816

  Wagner, Brett A ^a   Buettner, Garry R ^a   Oberley, Larry W ^a   Burns, C Patrick ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; EDELFOSINE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; TRYPAN BLUE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN HL 60; CELL STRAIN K 562; CONCENTRATION RESPONSE; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG SENSITIVITY; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; OXIDATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ASCORBIC ACID; CELL MEMBRANE; FATTY ACIDS; FLOW CYTOMETRY; FREE RADICALS; HL-60 CELLS; HUMANS; INDICATORS AND REAGENTS; IRON; LIPID PEROXIDATION; NITROGEN OXIDES; PHOSPHOLIPID ETHERS; PROPIDIUM; REACTIVE OXYGEN SPECIES; TRYPAN BLUE; TUMOR CELLS, CULTURED; VITAMIN E;

EID: 0032126489     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Tidwell, T., Guzman, G., and Vogler, W. R. The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562. Blood, 57: 794-797, 1981.
2. Berdel, W. E. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience. Lipids, 22: 970-973, 1987.
3. Hoffman, D. R., Hoffman, L. H., and Snyder, F. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. Cancer Res., 46: 5803-5809, 1986.
4. Kiss, Z., Deli, E., Vogler, W. R., and Kuo, J. F. Antileukemic agent alkyllysophospholipid regulates phosphorylation of distinct proteins in HL60 and K562 cells and differentiation of HL60 cells promoted by phorbol ester. Biochem. Biophys. Res. Commun., 142: 661-666, 1987.
5. Diomede, L., Bianchi, R., Modest, E. J., Piovani, B., Bubba, F., and Salmona, M. Modulation of ATPase activity by cholesterol and synthetic ether lipids in leukemic cells. Biochem. Pharmacol., 43: 803-807, 1992.
6. Shoji, M., Fukuhara, T., Winton, E. F., Berdel, W. E., and Vogler, W. R. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines. Exp. Hematol., 22: 13-18, 1994.
7. Vogler, W. R., Shoji, M., Hayzer, D. J., Xie, Y. P., and Renshaw, M. The effect of edelfosine on CTP:cholinephosphate cytidylyltransferase activity in leukemic cell lines. Leuk. Res., 20: 947-951, 1996.
8. Magistrelli, A., Villa. P., Benfenati, E., Modest, E. J., Salmona, M., and Tacconi, M. T. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver. Drug Metab. Dispos., 23: 113-118, 1995.
9. Wagner, B. A., Buettner, G. R., and Burns, C. P. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents. Cancer Res., 52: 6045-6051, 1992.
10. Wagner, B. A., Buettner, C. P., and Burns, C. P. Increased generation of lipid-derived and ascorbate free radicals by L1210 cells exposed to the ether lipid edelfosine. Cancer Res., 53: 711-713, 1993.
11. Wagner, B. A., Buettner, G. R., and Burns, C. P. Free radical-mediated lipid peroxidation in cells: oxidizability is a function of the cell lipid bis-allylic hydrogen content. Biochemistry, 33: 4449-4453, 1994.
12. Wagner, B. A., Buettner, G. R., and Burns, C. P. Vitamin E slows the rate of free radical-mediated lipid peroxidation in cells. Arch. Biochem. Biophys., 334: 261-267, 1996.
13. Buettner, G. R., Kelley, E. E., and Burns, C. P. Membrane lipid free radicals produced from L1210 murine leukemia cells by Photofrin photosensitization: an electron paramagnetic resonance spin trapping study. Cancer Res., 53: 3670-3673, 1993.
14. Kelley, E. E., Buettner, G. R., and Burns, C. P. Production of lipid-derived free radicals in L1210 murine leukemia cells is an early event in the photodynamic action of Photofrin. Photochem. Photobiol., 65: 576-580, 1997.
15. Folch, J., Lees, M., and Sloane-Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226: 497-509, 1957.
16. Morrison, W. R., and Smith, L. M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res., 5: 600-608, 1964.
17. Oberley, L. W., and Spitz, D. R. Nitroblue tetrazolium. In: R. Greenwald (ed.), CRC Handbook of Methods for Oxygen Radical Research, pp. 217-220. Boca Raton, FL: CRC Press, 1985.
18. Spitz, D. R., and Oberley, L. W. An assay for Superoxide dismutase activity in mammalian tissue homogenates. Anal. Biochem., 179: 8-18, 1989.
19. Aebi, H. Catalase in vitro. In: L. Packer (ed), Methods in Enzymology, Vol. 105, pp. 121-126. Orlando: Academic Press, 1984.
20. Lawrence, R., and Burk, R. Glutathione peroxidase activity in selenium deficient rat liver. Biochem. Biophys. Res. Commun., 71: 952-958, 1976.
21. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca W., Hotz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
22. Minn, A. J., Rudin, C. M., Boise, L. H., and Thompson, C. B. Expression of Bcl-xL can confer a multidrug resistance phenotype. Blood, 86: 1903-1910, 1995.
23. Dive, C., Gregory, C. D., Phipps, D. J., Evans, D. L., Milner, A. E., and Wyllie, A. H. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta, 1133: 275-285, 1992.
24. Buettner, G. R., and Jurkiewicz, B. A. Ascorbate free radical as a marker of oxidative stress: an EPR study. Free Radical Biol. Med., 14: 49-55, 1993.
25. Principe, P., and Braquet, P. Advances in ether phospholipids treatment of cancer. Crit. Rev, Oncol./Hematol., 18: 155-178, 1995.
26. Andreesen, R., Modolell, M., Weltzien, H. U., Eibl, H., Common, H. H., Löhr, G. W., and Munder, P. G. Selective destruction of human leukemic cells by alky-lysophospholipids. Cancer Res., 38: 3894-3899, 1978.
27. Glasser, L., Somberg, L. B., and Vogler, W. R. Purging murine leukemic marrow with alkyl-lysophospholipids. Blood, 64: 1288-1291, 1984.
28. Drings, P., Günther, I., Gatzemeier, U., Ulbrich, F., Khanavkar, B., Schreml, W., Lorenz, J., Brugger, W., Schick, H. D., Panel, J. V., and Nordström, R. Final evaluation of a phase II study on the effect of edelfosine (an ether lipid) in advanced non-small-cell bronchogenic carcinoma. Onkologie, 15: 375-382, 1992.
29. Dummer, R., Krasovec, M., Roger, J., Sindermann, H., and Burg, G. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study. J. Am. Acad. Dermatol., 29: 963-970, 1993.
30. Lohmeyer, M., and Bittman, R. Antitumor ether lipids and alkylphosphocholines. Drugs Future, 19: 1021-1027, 1994.
31. Vogler, W. R., Berdel, W. E., Olson, A. C., Winton, E. F., Heffner, L. T., and Gordon, D. S. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid. Blood, 80: 1423-1429, 1992.
32. Dietzfelbinger, H. F., Kuhn, D., Zafferani, M., Hanauske, A. R., Rastetter, J. W., and Berdel, W. E. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Cancer Res., 53: 3747-3751, 1993.
33. Vogler, W. R. Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs. Leukemia Lymphoma 13: 53-60, 1994.
34. Koenigsmann, M. P., Notter, M., Knauf, W. U., Papadimitriou, C. A., Oberberg, D., Reufi, B., Mucke, C., Thiel, E., and Berdel, W. E. Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy. Bone Marrow Transplant., 18: 549-557, 1996.
35. Storme, G. A., Berdel, W. E., van Blitterswijk, W. J., Bruyneel, E. A., De Bruyne, G. K., and Mareel, M. M. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro. Cancer Res., 45: 351-357, 1985.
36. Long, R. C., Small, W. C., Brynes, R. K., Tidwell, T., Goldstein, J. H., and Vogler, W. R. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance. Cancer Res., 43: 770-775, 1983.
37. Berdel, W. E., Greiner, E., Fink, U., Zanker, K. S., Stavrou, D., Trappe, A., Fahlbusch, R., Reichert, A., and Rastetter, J. Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells. Oncology, 41: 140-145, 1984.
38. Noseda, A., White, J. G., Godwin, P. L., Jerome, W. G., and Modest, E. J. Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study. Exp. Mol. Pathol., 50: 69-83, 1989.
39. King, M-T., Eckhardt, K., Gocke, E., Wild, D., Berdel, W. E., and Munder, P. G. Failure to detect mutagenic effects of anti-tumor alkyl-lysophospholipids. Cancer Lett., 12: 217-222, 1981.
40. Bauchinger, M., Dresp, J., Schmid, E., and Berdel, W. E. Cytogenetic effects of an alkyl-lysophospholipid derivative in human peripheral lymphocytes exposed in vitro and in vivo. Mutat. Res., 121: 225-231, 1983.
41. 4L Noseda, A., Berens, M. E., Piantadosi, C., and Modest, E. J. Neoplastic cell inhibition with new ether lipid analogs. Lipids, 22: 878-883, 1987.
42. Modolell, M., Andreesen, R., Pahlke, W., Brugger, W., and Munder, P. G. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. Cancer Res., 39: 4681-4686, 1979.
43. Honma, Y., Kasukabe, T., Okabe-Kado, J., Hozumi, M., Tsushima, S., and Nomura, H. Antileukemic effect of alkyl phospholipids. I. Inhibition of proliferation and induction of differentiation of cultured myeloid leukemia cells by alkyl ethylenegly-cophospholipids. Cancer Chemother. Pharmacol., 11: 73-76, 1983.
44. Munder, P. G., and Westphal, O. Antitumoral and other biomedical activities of synthetic ether lysophospholipids. In: B. H. Waksman (ed.), 1939-1989: Fifty Years Progress in Allergy. Chem. Immunol., Vol. 49, pp. 206-235. Basel: Karger, 1990.
45. 2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid. Cancer Res., 43: 2955-2961, 1983.
46. van Blitterswijk, W. J., van der Bend, R. L., Kramer, Ï. M., Verhoeven, A. J., Hilkmann, H., and de Widt, J. A Metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C. Lipids, 22: 842-846, 1987.
47. Marx, M. H., Piantadosi, C., Noseda, A., Daniel, L. W., and Modest, E. J. Synthesis and evaluation of neoplastic cell growth inhibition of 1-N-alkylamide analogues of glycero-3-phosphocholine. J. Med. Chem., 31: 858-863, 1988.
48. Powis, G., Seewald, M. J., Gratas, C., Melder, D., Riebow, J., and Modest, E. J. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res., 52: 2835-2840, 1992.
49. 2+ signaling by antitumor ether lipid analogues. Cancer Res., 50: 4458-4463, 1990.
50. Honma, Y., Kasukabe, T., Hozumi, M., Tsushima, S., and Nomura, H. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids. Cancer Res., 41: 3211-3216, 1981.
51. McNamara, M. J. C., Schmitt, J. D., Wykle, R. L., and Daniel, L. W. 1-O-Hexadecyl-2-acetyl-sn-glycerol stimulates differentiation of HL-60 human promyelocytic leukemia cells to macrophage-like cells. Bichem. Biophys. Res. Commun., 122: 824-830, 1984.
52. Gardner, H. W. Oxygen radical chemistry of polyunsaturated fatty acids. Free Radical Biol. Med., 7: 65-86, 1989.
53. Lohmeyer, M., and Workman, P. Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids. Br. J. Cancer, 72: 277-286, 1995.
54. Kelley, E. E., Modest, E. J., and Bums, C. P. Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells. Biochem. Pharmacol., 45: 2435-2439, 1993.
55. Diomede, L., Colotta, F., Piovani, B., Re, F., Modest, E. J., and Salmona, M. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int. J. Cancer, 53: 124-130, 1993.
56. Diomede, L., Piovani, B., Re, F., Principe, P., Colotta, F., Modest, E. J., and Salmona, M. The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells. Int. J. Cancer, 57: 645-649, 1994.